Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective self-controlled study.
Chongsheng ChengWenshuai XuYani WangTengyue ZhangLuning YangWangji ZhouDanjing HuYanli YangXinlun TianKai-Feng XuPublished in: Orphanet journal of rare diseases (2022)
Sirolimus reduced the risk of pneumothorax recurrence in LAM patients.